01 Record
CVE-2020-27268
In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically
UnratedPUBLISHEDCNA: icscert
CNA base scoreUnratedNo CNA CVSS vector
02 Description
In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically
03 Exploitation and scoring
- Exploitation
- Not assessed. CISA has not published an exploitation assessment for this record, and it is not in the KEV catalog. That is an absence of assessment, not a finding of no risk.
- SSVC decision
- Not assessed by CISA
- EPSS probability
- 0.54% probability of exploitation activity in the next 30 days.
- EPSS percentile
- Equal to or higher than the score of 45.4% of scored records. A rank, not a probability.
- NVD base score
- 6.5 (CVSS v3.x), scored by the NVD independently of the CNA.
- NVD CVSS vector
- CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
- NVD analysis status
- Modified. NVD last modified this record on 2026-06-17.
- Red Hat severity
- No Red Hat rating. Red Hat rates the CVEs that affect its products.
Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.
04 Metadata
- Published
- 2021-01-19 21:17Z5 YR AGO
- Last updated
- 2024-08-04 16:11Z2 YR AGO
- Reserved
- 2020-10-19
- Assigning CNA
- icscert
- Record state
- PUBLISHED
- Severity
- Not rated by the issuing CNA
- CNA CVSS vector
- Not published by the issuing CNA
- Weaknesses
- Data version
- 5.1
- Document digest
- 34a97e41d1827a9588248483455d6afd36c8f98bb76a6f6a672d5c1e1a045667
05 Affected products
VendorProductVersionsPlatforms
n/aSOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-ADana Diabecare RS, AnyDana-i, AnyDana-A All versions prior to 3.0—
06 References
- us-cert.cisa.govhttps://us-cert.cisa.gov/ics/advisories/icsma-21-012-01